Mario Škugor, M.D. FACE

Clinical Assistant Professor of Medicine- Cleveland Clinic

I graduated Medical school in 1986 and spent 2 years as research associate in Institute for Nuclear Medicine in Zagreb. During 1991-1992 I was in the Croatian army. In 1993 I finished Nuclear Medicine Residency. During 1993-1997 I was at Ohio State University as researcher in Bone and Mineral Metabolism Laboratory. I did Internal Medicine residency in 1997-2000 at St. Luke’s Medical Center in Cleveland. I served as a chief resident the last year.  Endocrinology fellowship in Cleveland Clinic was from 2000-2002. I have been on staff in Cleveland Clinic since. I served on Board of Directors of Ohio River Valley Chapter of American Association of Clinical Endocrinologists and was a president in 2007-2008.

I was associated director of endocrinology fellowship program 2009-2011. I was Vice-Chairman of the Global Patient Services at Cleveland Clinic from 2009-2013 and Interim Chairman from 2013-2014. I am a clinical associate professor of medicine, and director of PBL case development at Cleveland Clinic Lerner College of Medicine of CWRU and hold the Catherine and Edward Lozick chair in Endocrinology and Metabolism.

Presentation title: Medical Tourism


The number of medical tourists in 2017 was estimated at 14-16 million word wide. The number of medical tourists in the world is increasing by 15-25% per year. Estimated $45-$72 billion is spent yearly globally, but entire medical tourist business is about $439 billion per year. Number of countries solicit medical tourism. Health care brokerages are proliferating to help arrange medical visits. Several US medical centers (Harvard, Boston University, Johns Hopkins, Cleveland Clinic) opened hospitals around the world to capitalize on globalization of medicine.

Most sought services are dentistry, fertility procedures, cosmetic and weight loss surgeries. The primary concern of medical tourists is the quality of the care. The Joint Commission accredits hospitals outside the and 800 hospitals had been accredited in 2017, increasing by 20% yearly. Concerns about liability and late complications still exist and are being addressed by various insurances.